🇯🇵·Jan 1, 1970Industry
Dec. 27. 2022 Sawai Pharmaceutical Applies for Marketing and Manufacturing Approval for Non-Invasive Neuromodulation Device
Publisher
S
Sawai Pharmaceutical
Japan
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Sawai Pharmaceutical
- Region
- Japan
- Scope
- Industry
- Published
- January 1, 1970
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on global.sawai.co.jp
Leave the platform to read the original full article on the publisher site.
Source: Sawai Pharmaceutical
Scope: Industry
Related coverage
More related coverage
Recordati/9h ago
RECORDATI: SOLID MOMENTUM OF THE GROUP CONTINUES FIRST HALF 2026. NET REVENUE +6.6%, EBITDA +8.8%, ADJUSTED NET INCOME +6.7%
<![CDATA[Intermountain Health Newsroom]]>/11h ago
Utah Family and Toddler Who Nearly Died in Uruguay to Reunite on Wednesday with Intermountain Health Flight Team Who Beat the Odds to Save Her Life
Apple Health Newsroom/12h ago
Apple Upgrade launches in the United States
GSK News/13h ago